Cargando…

Originating multiple-objective portfolio selection by counter-COVID measures and analytically instigating robust optimization by mean-parameterized nondominated paths

The COVID-19 pandemic is unleashing crises of humanity, economy, and finance. Portfolio selection is widely recognized as the foundation of modern financial economics. Therefore, it is naturally crucial and inviting to utilize portfolio selection in order to counter COVID-19 in stock markets. We ori...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Yue, Liao, Kezhi, Liu, Tongyang, Zhang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476468/
http://dx.doi.org/10.1016/j.orp.2022.100252
_version_ 1784790144483590144
author Qi, Yue
Liao, Kezhi
Liu, Tongyang
Zhang, Yu
author_facet Qi, Yue
Liao, Kezhi
Liu, Tongyang
Zhang, Yu
author_sort Qi, Yue
collection PubMed
description The COVID-19 pandemic is unleashing crises of humanity, economy, and finance. Portfolio selection is widely recognized as the foundation of modern financial economics. Therefore, it is naturally crucial and inviting to utilize portfolio selection in order to counter COVID-19 in stock markets. We originate a counter-COVID measure for stocks, extend portfolio selection, and construct multiple-objective portfolio selection. Because of the uncertainty in measuring counter-COVID, we perform robust optimization. Specifically, we analytically compute the optimal solutions as a trail of an optimal portfolio due to the change of counter-COVID. We call the trail as mean-parameterized nondominated path. Moreover, the path is a continuous function of the change, so the portfolio relatively mildly varies for the change. In contrast, researchers typically still focus on 2-objective robust illustrations and infrequently explicitly compute the optimal solutions for multiple-objective portfolio optimization. To the best of our knowledge, there is limited research for multiple-objective portfolio selection of COVID and for the robust optimization of multiple-objective portfolio selection. In such an area, this paper contributes to the literature. The implications to fight COVID are that investors minimize risk, maximize return, and maximize counter-COVID in stock markets and that investors ascertain the multiple-objective portfolio selection as relatively robust.
format Online
Article
Text
id pubmed-9476468
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-94764682022-09-15 Originating multiple-objective portfolio selection by counter-COVID measures and analytically instigating robust optimization by mean-parameterized nondominated paths Qi, Yue Liao, Kezhi Liu, Tongyang Zhang, Yu Operations Research Perspectives Article The COVID-19 pandemic is unleashing crises of humanity, economy, and finance. Portfolio selection is widely recognized as the foundation of modern financial economics. Therefore, it is naturally crucial and inviting to utilize portfolio selection in order to counter COVID-19 in stock markets. We originate a counter-COVID measure for stocks, extend portfolio selection, and construct multiple-objective portfolio selection. Because of the uncertainty in measuring counter-COVID, we perform robust optimization. Specifically, we analytically compute the optimal solutions as a trail of an optimal portfolio due to the change of counter-COVID. We call the trail as mean-parameterized nondominated path. Moreover, the path is a continuous function of the change, so the portfolio relatively mildly varies for the change. In contrast, researchers typically still focus on 2-objective robust illustrations and infrequently explicitly compute the optimal solutions for multiple-objective portfolio optimization. To the best of our knowledge, there is limited research for multiple-objective portfolio selection of COVID and for the robust optimization of multiple-objective portfolio selection. In such an area, this paper contributes to the literature. The implications to fight COVID are that investors minimize risk, maximize return, and maximize counter-COVID in stock markets and that investors ascertain the multiple-objective portfolio selection as relatively robust. The Authors. Published by Elsevier Ltd. 2022 2022-09-15 /pmc/articles/PMC9476468/ http://dx.doi.org/10.1016/j.orp.2022.100252 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Qi, Yue
Liao, Kezhi
Liu, Tongyang
Zhang, Yu
Originating multiple-objective portfolio selection by counter-COVID measures and analytically instigating robust optimization by mean-parameterized nondominated paths
title Originating multiple-objective portfolio selection by counter-COVID measures and analytically instigating robust optimization by mean-parameterized nondominated paths
title_full Originating multiple-objective portfolio selection by counter-COVID measures and analytically instigating robust optimization by mean-parameterized nondominated paths
title_fullStr Originating multiple-objective portfolio selection by counter-COVID measures and analytically instigating robust optimization by mean-parameterized nondominated paths
title_full_unstemmed Originating multiple-objective portfolio selection by counter-COVID measures and analytically instigating robust optimization by mean-parameterized nondominated paths
title_short Originating multiple-objective portfolio selection by counter-COVID measures and analytically instigating robust optimization by mean-parameterized nondominated paths
title_sort originating multiple-objective portfolio selection by counter-covid measures and analytically instigating robust optimization by mean-parameterized nondominated paths
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476468/
http://dx.doi.org/10.1016/j.orp.2022.100252
work_keys_str_mv AT qiyue originatingmultipleobjectiveportfolioselectionbycountercovidmeasuresandanalyticallyinstigatingrobustoptimizationbymeanparameterizednondominatedpaths
AT liaokezhi originatingmultipleobjectiveportfolioselectionbycountercovidmeasuresandanalyticallyinstigatingrobustoptimizationbymeanparameterizednondominatedpaths
AT liutongyang originatingmultipleobjectiveportfolioselectionbycountercovidmeasuresandanalyticallyinstigatingrobustoptimizationbymeanparameterizednondominatedpaths
AT zhangyu originatingmultipleobjectiveportfolioselectionbycountercovidmeasuresandanalyticallyinstigatingrobustoptimizationbymeanparameterizednondominatedpaths